Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

First launch for lepirudin

June 5, 1997

Orally active antiplatelet agents described by Taisho

June 3, 1997

Astra shifts focus to newer thrombin inhibitor

June 2, 1997

Wyeth-Ayerst's Normiflo approved for prevention of deep vein thrombosis

June 2, 1997

Nissan Chem. reveals antiplatelet agents

May 29, 1997

Neutralase effective for heparin reversal in CAB

May 27, 1997

Texas Biotechnology reports phase III results with Novastan in HIT and HITTS

May 23, 1997

Molecumetics and Asahi enter anticoagulant collaboration

May 22, 1997

Ibex Technologies presents data on heparin neutralization agent

May 21, 1997

Selective thrombin inhibitors revealed by HMR

May 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...